First-in-human study of a novel radiolabeled fibroblast activating protein (FAP)-targeted peptide 68Ga-FAP-3BP-3940 for PET/CT imaging in patients with solid tumors

被引：0
|
作者：
Jakobsson, Vivianne [1 ]
Zhang, Jingjing [2 ]
Greifenstein, Lukas [1 ]
Huang, Juncheng
Chen, Xiaoyuan [3 ]
Baum, Richard P. [1 ]
机构：
[1] Curanosticum Wiesbaden Frankfurt, Frankfurt, Germany
[2] Natl Univ Singapore NUS, Singapore, Singapore
[3] NUS, Singapore, Singapore
来源：
JOURNAL OF NUCLEAR MEDICINE | 2023年 / 64卷
关键词：
D O I：
暂无
中图分类号：
R8 [特种医学]; R445 [影像诊断学];
学科分类号：
1002 ; 100207 ; 1009 ;
摘要：
P1615
引用
收藏
页数：2
相关论文
共 17 条
  • [1] A highly potent FAP-targeting peptide for theranostics: production, validation and first in human experience with Ga-68 and Lu-177 3BP-3940
    Greifenstein, Lukas
    Gunkel, Annika
    Hoehne, Aileen
    Osterkamp, Frank
    Smerling, Christiane
    Landvogt, Christian
    Mueller, Corinna
    Baum, Richard P.
    JOURNAL OF NUCLEAR MEDICINE, 2024, 65
  • [2] 3BP-3940, a highly potent FAP-targeting peptide for theranostics- production, validation and first in human experience with Ga-68 and Lu-177
    Greifenstein, Lukas
    Gunkel, Annika
    Hoehne, Aileen
    Osterkamp, Frank
    Smerling, Christiane
    Landvogt, Christian
    Mueller, Corinna
    Baum, Richard P.
    ISCIENCE, 2023, 26 (12)
  • [3] First-in-human PET/CT Imaging of somatostatin receptor expressing tumors with the novel somatostatin receptor antagonist 68Ga-NODAGA-LM3-a comparison with 68Ga-DOTATOC PET/CT
    Singh, A.
    Kulkarni, H. R.
    Langbein, T.
    Mueller, D.
    Senftleben, S.
    Fani, M.
    Maecke, H.
    Baum, R. P.
    EUROPEAN JOURNAL OF NUCLEAR MEDICINE AND MOLECULAR IMAGING, 2017, 44 : S184 - S185
  • [4] Comparative Evaluation of a Novel FAP-targeted Radioactive [68Ga]Ga-XT117 and [18F]F-FDG in Patients with Solid Tumors: A Pilot Clinical PET Imaging Study
    Shen, Zhihui
    Wang, Ruimin
    JOURNAL OF NUCLEAR MEDICINE, 2024, 65
  • [5] Preliminary study of a novel FAP-targeted ligand 68Ga-DOTA-FL in colon cancer imaging using small-animal PET/CT
    Zhan Xu
    Yimeng Shi
    Hongyan Yin
    Jing Lv
    Clinical and Translational Imaging, 2024, 12 : 91 - 97
  • [6] Preliminary study of a novel FAP-targeted ligand 68Ga-DOTA-FL in colon cancer imaging using small-animal PET/CT
    Xu, Zhan
    Shi, Yimeng
    Yin, Hongyan
    Lv, Jing
    CLINICAL AND TRANSLATIONAL IMAGING, 2024, 12 (01) : 91 - 97
  • [7] Preclinical evaluation and first-in-human imaging of [203/212Pb]Pb-PSV359, a novel cyclic peptide targeting fibroblast activation protein-alpha (FAP)
    Cagle, B.
    Baumhover, N. J.
    Thakral, P.
    Malik, D.
    Vance, I. N.
    Liu, D.
    Rodman, S. N.
    Kalen, A. L.
    Kapoor, S.
    Sagastume, E. A.
    Johnson, F. L.
    Schultz, M. K.
    Sen, I. B.
    Li, M.
    EUROPEAN JOURNAL OF NUCLEAR MEDICINE AND MOLECULAR IMAGING, 2024, 51 : S227 - S227
  • [8] Preclinical study and first-in-human imaging of [18F]FAP-2286, and comparison with 2-[18F]FDG PET/CT in various cancer patients
    Liu, Lifang
    Zhong, Jiawei
    Zhang, Ziqi
    Ye, Xiaoting
    Wang, Xinlu
    Liu, Shaoyu
    Zhang, Zhanwen
    EUROPEAN JOURNAL OF NUCLEAR MEDICINE AND MOLECULAR IMAGING, 2024, 51 (07) : 2012 - 2022
  • [9] Simulation of PET/CT clinical data for the rational design of a first in human imaging study of a 68Ga labeled Guanylyl Cyclase C targeted peptide
    Hesterman, J. Y.
    EUROPEAN JOURNAL OF NUCLEAR MEDICINE AND MOLECULAR IMAGING, 2014, 41 : S555 - S555
  • [10] First-in-human study of a novel somatostatin receptor antagonist 68Ga-NODAGA-LM3 for molecular imaging of paraganglioma patients
    Singh, Aviral
    Zhang, Jingjing
    Kulkarni, Harshad
    Langbein, Thomas
    Baum, Richard
    JOURNAL OF NUCLEAR MEDICINE, 2019, 60
12